Towards Healthcare
Viral Vector Gene Therapy Market Size and Emerging Trends by 2034

Viral Vector Gene Therapy Market Gene Therapy Gains Momentum

The viral vector gene therapy market is growing due to rising demand for targeted treatments for genetic and rare diseases. Advancements in biotechnology and increasing clinical approvals are also fueling market expansion. 

  • Insight Code: 5737
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The viral vector gene therapy market is rapidly emerging, driven by biotech advances and rising demand for innovative genetic treatments from 2024 to 2034.

North America is currently leading the viral vector gene therapy Market due to its ability to accelerate drug discovery and optimize personalized treatment strategies.

Some key players include Novartis AG, Spark, Therapeutics, Merck KGaA, Regenxbio, and Uniqure NV.

The AI in Cancer Drugs Market includes 4 segments such as by vector type, application, end-user, and by region.

Key trends include the ability to accelerate drug discovery and optimize personalized treatment strategies.

Adeno-associated virus (AAV), lentivirus, adenovirus, and retrovirus are commonly used due to their ability to enter human cells and deliver genetic material.

Clinical trials and approved therapies have shown promising safety, but risks include immune responses, insertional mutagenesis, or off-target effects.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.